TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Polynovo ( (AU:PNV) ) has shared an announcement.
PolyNovo Limited has requested a trading halt on its securities pending the release of an announcement. This move is in response to press speculation about a potential positive change in U.S. reimbursement for outpatient wound care, which could significantly impact the company’s operations and market positioning.
The most recent analyst rating on (AU:PNV) stock is a Hold with a A$1.30 price target. To see the full list of analyst forecasts on Polynovo stock, see the AU:PNV Stock Forecast page.
More about Polynovo
PolyNovo Limited operates in the medical technology industry, focusing on developing and commercializing innovative wound care solutions. The company is known for its advanced products aimed at improving patient outcomes and changing lives, with a particular market focus on outpatient wound care.
YTD Price Performance: -35.54%
Average Trading Volume: 2,428,287
Technical Sentiment Signal: Sell
Current Market Cap: A$908.5M
For a thorough assessment of PNV stock, go to TipRanks’ Stock Analysis page.